We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Post-translational modifications in the context of therapeutic proteins.
- Authors
Walsh, Gary; Jefferis, Roy
- Abstract
The majority of protein-based biopharmaceuticals approved or in clinical trials bear some form of post-translational modification (PTM), which can profoundly affect protein properties relevant to their therapeutic application. Whereas glycosylation represents the most common modification, additional PTMs, including carboxylation, hydroxylation, sulfation and amidation, are characteristic of some products. The relationship between structure and function is understood for many PTMs but remains incomplete for others, particularly in the case of complex PTMs, such as glycosylation. A better understanding of such structural-functional relationships will facilitate the development of second-generation products displaying a PTM profile engineered to optimize therapeutic usefulness.
- Publication
Nature biotechnology, 2006, Vol 24, Issue 10, p1241
- ISSN
1087-0156
- Publication type
Journal Article
- DOI
10.1038/nbt1252